BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15106801)

  • 1. Heterozygous disruption of CMA1 does not affect blood pressure.
    Ono K; Kokubo Y; Mannami T; Inamoto N; Shioji K; Iwai N
    J Hypertens; 2004 Jan; 22(1):103-9. PubMed ID: 15106801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism of the mast cell chymase gene (CMA1) promoter region: lack of association with asthma but association with serum total immunoglobulin E levels in adult atopic dermatitis.
    Iwanaga T; McEuen A; Walls AF; Clough JB; Keith TP; Rorke S; Barton SJ; Holgate ST; Holloway JW
    Clin Exp Allergy; 2004 Jul; 34(7):1037-42. PubMed ID: 15248847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of mast cell chymase polymorphisms with atopy.
    Weidinger S; Rümmler L; Klopp N; Wagenpfeil S; Baurecht HJ; Fischer G; Holle R; Gauger A; Schäfer T; Jakob T; Ollert M; Behrendt H; Wichmann HE; Ring J; Illig T
    Allergy; 2005 Oct; 60(10):1256-61. PubMed ID: 16134991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chymase gene (CMA1) polymorphisms in Dutch and Japanese sarcoidosis patients.
    Kruit A; Grutters JC; Ruven HJ; Sato H; Izumi T; Nagai S; Welsh KI; du Bois RM; van den Bosch JM
    Respiration; 2006; 73(5):623-33. PubMed ID: 16446531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of polymorphisms in the mast cell chymase gene promoter region (-1903 g/A) and (TG)n(GA)m repeat downstream of the gene with bronchial asthma in children.
    Hossny EM; Amr NH; Elsayed SB; Nasr RA; Ibraheim EM
    J Investig Allergol Clin Immunol; 2008; 18(5):376-81. PubMed ID: 18973102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension.
    Benjafield AV; Wang WY; Morris BJ
    Am J Hypertens; 2004 Jul; 17(7):624-8. PubMed ID: 15233982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphisms in the interleukin-6 gene associated with blood pressure and atherosclerosis in a Japanese general population.
    Tanaka C; Mannami T; Kamide K; Takiuchi S; Kokubo Y; Katsuya T; Kawano Y; Miyata T; Ogihara T; Tomoike H
    Hypertens Res; 2005 Jan; 28(1):35-41. PubMed ID: 15969253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of sodium channel gamma-subunit promoter variant with blood pressure.
    Iwai N; Baba S; Mannami T; Katsuya T; Higaki J; Ogihara T; Ogata J
    Hypertension; 2001 Jul; 38(1):86-9. PubMed ID: 11463765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene polymorphisms of the renin-angiotensin system and age-related changes in systolic and diastolic blood pressure in subjects with hypertension.
    Rudnichi A; Safar ME; Lajemi M; Benetos A
    Am J Hypertens; 2004 Apr; 17(4):321-7. PubMed ID: 15062885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women.
    Mansego ML; Redon J; Marin R; González-Albert V; Martin-Escudero JC; Fabia MJ; Martinez F; Chaves FJ
    J Hypertens; 2008 Feb; 26(2):230-7. PubMed ID: 18192836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative association between a newly identified molecular variant in the endothelin-2 gene and human essential hypertension.
    Sharma P; Hingorani A; Jia H; Hopper R; Brown MJ
    J Hypertens; 1999 Sep; 17(9):1281-7. PubMed ID: 10489105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of (pro)renin receptor gene polymorphism with blood pressure in Japanese men: the Ohasama study.
    Hirose T; Hashimoto M; Totsune K; Metoki H; Asayama K; Kikuya M; Sugimoto K; Katsuya T; Ohkubo T; Hashimoto J; Rakugi H; Takahashi K; Imai Y
    Am J Hypertens; 2009 Mar; 22(3):294-9. PubMed ID: 19131936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a mast cell chymase gene variant with HDL cholesterol, but not with blood pressure in the Ohasama study.
    Fukuda M; Ohkubo T; Katsuya T; Hozawa A; Asai T; Matsubara M; Kitaoka H; Tsuji I; Araki T; Satoh H; Higaki J; Hisamichi S; Imai Y; Ogihara T
    Hypertens Res; 2002 Mar; 25(2):179-84. PubMed ID: 12047032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 21 single nucleotide polymorphisms in human hepatocyte growth factor gene and association with blood pressure and carotid atherosclerosis in the Japanese population.
    Takiuchi S; Mannami T; Miyata T; Kamide K; Tanaka C; Kokubo Y; Koyama Y; Inamoto N; Katsuya T; Iwai N; Kawano Y; Ogihara T; Tomoike H
    Atherosclerosis; 2004 Apr; 173(2):301-7. PubMed ID: 15064106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.
    Hallberg P; Karlsson J; Kurland L; Lind L; Kahan T; Malmqvist K; Ohman KP; Nyström F; Melhus H
    J Hypertens; 2002 Oct; 20(10):2089-93. PubMed ID: 12359989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.
    Bhatnagar V; O'Connor DT; Schork NJ; Salem RM; Nievergelt CM; Rana BK; Smith DW; Bakris GL; Middleton JP; Norris KC; Wright JT; Cheek D; Hiremath L; Contreras G; Appel LJ; Lipkowitz MS
    J Hypertens; 2007 Oct; 25(10):2082-92. PubMed ID: 17885551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chymase gene locus is not associated with myocardial infarction and is not linked to heart size or blood pressure.
    Pfeufer A; Busjahn A; Vergopoulos A; Knoblauch H; Urata H; Osterziel KJ; Menz M; Wienker TF; Faulhaber HD; Steinmetz A; Schuster H; Dietz R; Luft FC
    Am J Cardiol; 1998 Oct; 82(8):979-81. PubMed ID: 9794357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of angiotensin II type 1-receptor gene polymorphisms with the risk of developing hypertension in Mexican individuals.
    Martínez-Rodríguez N; Posadas-Romero C; Cardoso G; Pérez-Rodríguez JM; Pérez-Hernández N; Vallejo M; Vargas-Alarcón G
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):133-40. PubMed ID: 21846682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk given by AGT polymorphisms in inducing susceptibility to essential hypertension among isolated populations from a remote region of China: A case-control study among the isolated populations.
    Li Q; Sun L; Du J; Ran P; Gao T; Yuan Y; Xiao C
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1202-17. PubMed ID: 26391364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.